Chosa Oncology AB (DB: W5L)
Health Care · Biotechnology · SE
€0.04
0.00% today · -58.0% 1Y
Public summary
A free snapshot of Chosa Oncology AB, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Chosa Oncology AB (DB: W5L) operates in the Biotechnology industry within the Health Care sector. The company is valued at $4.19M.
Over the last twelve months the share price has lost 58.0%, trading between 0.00 and 0.09.
Tweenvest scores Chosa Oncology AB across four factors: quality 50/100, value 59/100. Its strongest factor is value.
W5L price history
Key figures
- Market cap
- $4.19M
- Revenue (TTM)
- —
- P/E
- -3.58
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.65
- 52-week high
- €0.09
- 52-week low
- €0.00
- Avg volume (3M)
- —
- Shares outstanding
- 91.44M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bio Green Med Solution, Inc.NasdaqCM: BGMS | $4.31M | $0.65 | +1.55% |
| Kane Biotech Inc.TSXV: KNE | $4.30M | CA$0.03 | 0.00% |
| America Great HealthOTCPK: AAGH | $4.23M | $0.00 | +100.00% |
| LianMedicalOTCPK: LIAN.Y | $4.20M | $0.04 | -20.49% |
| Bharat Immunologicals & Biologicals Corporation LimitedBSE: 524663 | $4.14M | Rs9.01 | +0.22% |
| Alaunos Therapeutics, Inc.NasdaqCM: TCRT | $4.14M | $1.63 | +0.62% |
| GRI Bio, Inc.NasdaqCM: GRI | $3.98M | $1.82 | -0.55% |
| Creative Medical Technology Holdings, Inc.NasdaqCM: CELZ | $3.95M | $0.52 | -1.51% |